Neuroleptic properties of the ion-channel-forming peptaibol zervamicin: Locomotor activity and behavioral effects

Chemistry and Biodiversity

Volumn 4, Issue 6, 2007, Pages 1374-1387

  Ovchinnikova, Tatiana V ^a   Levitskaya, Natalie G ^b   Voskresenskaya, Olga G ^b   Yakimenko, Zoya A ^a   Tagaev, Andrey A ^a   Ovchinnikova, Anastasia Y ^a   Murashev, Arkadiy N ^a   Kamenskii, Andrey A ^b  

^a SHEMYAKIN OVCHINNIKOV INSTITUTE OF BIOORGANIC CHEMISTRY   (Russian Federation)

^b MOSCOW STATE UNIVERSITY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

PEPTAIBOL; UNCLASSIFIED DRUG; ZERVAMICIN IIA; ZERVAMICIN IIB; ION CHANNEL; NEUROLEPTIC AGENT; PEPTIDE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; CONTROLLED STUDY; ENDURANCE; EXPLORATORY BEHAVIOR; FORCED SWIMMING TEST; LOCOMOTION; MALE; MAZE TEST; MOTOR COORDINATION; MOUSE; NONHUMAN; REARING; TRANQUILIZING ACTIVITY; ANIMAL; DOSE RESPONSE; DRUG EFFECT; MOTOR ACTIVITY;

ANIMALIA; EMERICELLOPSIS SALMOSYNNEMATA; FUNGI; MUS;

ANIMALS; ANTIPSYCHOTIC AGENTS; BEHAVIOR, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ION CHANNELS; MALE; MICE; MOTOR ACTIVITY; PEPTIDES;

EID: 34447334179     PISSN: 16121872     EISSN: 16121880     Source Type: Journal    
DOI: 10.1002/cbdv.200790117     Document Type: Article

References (25)

1. E. Benedetti, A. Bavoso, B. Di Blasio, V. Pavone, C. Pedone, C. Toniolo, G. M. Bonora, Proc. Natl. Acad. Sci. U.S.A. 1982, 79, 7951.
2. H. Brückner, H. Graf, Experientia 1983, 39, 528.
3. M. S. Sansom, Prog. Biophys. Mol. Biol. 1991, 55, 139.
4. I. L. Karle, P. Balaram, Biochemistry 1990, 29, 6747.
5. C. Toniolo, M. Crisma, F. Formaggio, C. Peggion, Biopolymers (Pept. Sci.) 2001, 60, 396.
6. A. D. Argoudelis, A. Dietz, L. E. Johnson, J. Antibiot. 1974, 27, 321.
7. J. Raap, K. Erkelens, A. Ogrel, D. A. Skladnev, H. Brückner, J. Pept. Sci. 2005, 11, 331.
8. I. L. Karle, J. Flippen-Anderson, M. Sukumar, P. Balaram, Proc. Natl. Acad. Sci. U.S.A. 1987, 84, 5087.
9. T. A. Balashova, Z. O. Shenkarev, A. A. Tagaev, T. V. Ovchinnikova, J. Raap, A. S. Arseniev, FEBS Lett. 2000, 466, 333.
10. D. M. Korzhnev, E. V. Bocharov, A. V. Zhuravleva, V. Y. Orekhov, T. V. Ovchinnikova, M. Billeter, A. S. Arseniev, FEBS Lett. 2001, 495, 52.
11. Z. O. Shenkarev, T. A. Balashova, R. G. Efremov, Z. A. Yakimenko, T. V. Ovchinnikova, J. Raap, A. S. Arseniev, Biophys J. 2002, 82, 762.
12. T. V. Ovchinnikova, Z. O. Shenkarev, Z. A. Yakimenko, N. V. Svishcheva, A. A. Tagaev, D. A. Skladnev, A. S. Arseniev, J. Pept. Sci. 2003, 9, 817.
13. Z. O. Shenkarev, A. S. Paramonov, T. A. Balashova, Z. A. Yakimenko, M. B. Baru, L. G. Mustaeva, J.Raap, T. V. Ovchinnikova, A. S. Arseniev, Biochem. Biophys. Res. Commun. 2004, 325, 1099.
14. Z. O. Shenkarev, T. A. Balashova, Z. A. Yakimenko, T. V. Ovchinnikova, A. S. Arseniev, Biophys. J. 2004, 86, 3687.
15. G. Nagaraj, M. V. Uma, M. S. Shivayogi, H. Balaram, Antimicrob. Agents Chemother. 2001, 45, 145.
16. M. Ritzau, S. Heinze, K. Dornberger, A. Berg, W. Fleck, B. Schlegel, A. Hartl, U. Grafe, J. Antibiot. 1997, 50, 722.
17. E. B. Thomson, 'Drug Bioscreening. Drug Evaluation Techniques in Pharmacology', VCH, New York, 1990, Chapt. 3, p. 25.
18. T. V. Ovchinnikova (Science-Educational Center, Shemyakin & Ovchinnikov, Institute of Bioorganic Chemistry), personal communication, July 2000.
19. T. V. Ovchinnikova, A. N. Murashev, Dokl. Biol. Sci. 2007, 414, 1.
20. H. Krugel, A. Becker, A. Polten, G. Grecksch, R. Singh, A. Berg, C. Seidenbecher, H. P. Saluz, J. Neurochem. 2006, 97, 74.
21. M. Tsuji, H. Takeda, T. Matsumiya, Br. J. Pharmacol. 2001, 134, 585.
22. J. C. Cole, R. J. Rodgers, Behav. Pharmacol. 1993, 4, 573.
23. R. D. Porsolt, M. Le Pichon, M. Jaifre, Nature 1977, 266, 730.
24. R. D. Porsolt, Rev. Neurosci. 2000, 11, 53.
25. M. P. Murphy, J. T. Rick, N. W. Milgram, G. O. Ivy, Neurobiol. Learn. Mem. 1995, 64, 181.